News for ImmuPharma plc (IMM.L)

The following is a round-up of earnings and trading updates of London-listed companies, issued on Wednesday and not separately reported by Alliance News: ---------- Challenger Energy Group PLC - ...

Major shareholding by Lanstead via TR1 14th September 2023 - 12:42 pm To view notification form click here Attachments Original Link ...

ImmuPharma PLC - London-based drug discovery and development company - Gets positive support and guidance from the US Food & Drug Administration after a pre-investigational new drug meeting,... | May 18, 2023

FDA confirms Type-C meeting date of 7th June 2023 for Phase 2/3 adaptive study of Lupuzor™ in lupus 20th April 2023 - 10:20 am ImmuPharma PLC , the specialist drug... | April 20, 2023

The following stocks are the leading risers and fallers on AIM in London on Wednesday. ---------- AIM - WINNERS ---------- System1 Group PLC, up 17% at 189.5 pence, 12-month range 115p-295p. The... | April 12, 2023

ImmuPharma PLC on Monday confirmed alongside its partner Avion Pharmaceuticals that a phase 2/3 adaptive trial will be the best design for the next clinical study of Lupuzor in systemic lupus... | February 6, 2023

Avion confirms its continued support to the Lupuzor™ clinical program in Lupus whilst exploring broader collaboration opportunities 18th November 2022 - 12:04 pm ... | November 18, 2022

The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: ---------- Synectics PLC - Sheffield, England-based security systems... | November 11, 2022

Read ImmuPharma (LON:IMM) Stock Price Passes Below Two Hundred Day Moving Average of $5.74 at ETF Daily News

Read ImmuPharma (LON:IMM) Shares Cross Below 200-Day Moving Average of $5.85 at ETF Daily News

Oriole Resources PLC has updated investors on the current work programmes on its West African projects during the first quarter of 2021. In Senegal, IAMGOLD has completed its... | January 18, 2021